AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ALPHA AMYLASE
18 registrations across 4 African markets— 12 active
Markets with ALPHA AMYLASE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MEGAMYLASE 200 UI SIROP FLACON DE 125ML | 🇨🇮Côte d'Ivoire | FRILAB SA | active | Mar 2027 |
| MAXILASE Sirop | 🇹🇳Tunisia | WINTHROP PHARMA TUNISIE | expired | Sept 2021 |
| MAXILASE Comprime enrobé / 3000 U | 🇹🇳Tunisia | WINTHROP PHARMA TUNISIE | expired | Aug 2021 |
| MAXILASE Comprime enrobé / 3000 U | 🇹🇳Tunisia | SANOFI AVENTIS PHARMA TUNISIE | expired | Jun 2008 |
| MAXILASE Sirop | 🇹🇳Tunisia | SANOFI AVENTIS PHARMA TUNISIE | expired | Sept 2003 |
| SUPRAMYLASE Sirop / 1000 U.CEIP/5ML | 🇹🇳Tunisia | SIPHAT | expired | Feb 1995 |
| SUPRAMYLASE Comprime enrobé / 3000 U.CEIP | 🇹🇳Tunisia | SIPHAT | expired | Feb 1995 |
| MAXILASE sirop / 200U/ml | 🇸🇳Senegal | SANOFI | active | — |
| MAXILASE 3000UI CP ENR (2X12) SANOFI-AVENTIS France comprimé 3000U (2X12) | 🇲🇬Madagascar | SANOFI AVENTIS France 2 | active | — |
| MAXILASE® SP (> 6 MOIS) GOUT MANDARINE BTE (1FL/125ML) sirop, Boîte de 1 flacon de | 🇲🇬Madagascar | SANOFI WINTHROP INDUSTRIE,, | active | — |
| MEGAMYLASE 200 SP(125, 250) FRILAB sirop à 200 U CEIP/ml | 🇲🇬Madagascar | FRILAB S.A. | active | — |
| MEGAMYLASE 200 SP(125, 250) FRILAB sirop à 200 U CEIP/ml | 🇲🇬Madagascar | FRILAB S.A. | active | — |
| MAXILASE 3000UI CP ENR (2X12) SANOFI-AVENTIS France comprimé 3000U (2X12) | 🇲🇬Madagascar | SANOFI AVENTIS France 2 | active | — |
| MAXILASE® SP (> 6 MOIS) GOUT MANDARINE BTE (1FL/125ML) sirop, Boîte de 1 flacon de | 🇲🇬Madagascar | SANOFI WINTHROP INDUSTRIE,, | active | — |
| MAXILASE sirop / 200U/ml | 🇸🇳Senegal | SANOFI | active | — |
| MAXILASE 3000 UI COMPRIME ENROBE BOITE DE 24 | 🇨🇮Côte d'Ivoire | SANOFI OPELLA | active | — |
| MAXILASE 200 UICEIP/ML SIROP FLACON DE 125ML | 🇨🇮Côte d'Ivoire | SANOFI OPELLA | active | — |
| MEGAMYLASE 3000 UI COMPRIME BOITE DE 24 | 🇨🇮Côte d'Ivoire | FRILAB SA | active | — |
ALPHA AMYLASE in Africa — Regulatory Overview
ALPHA AMYLASE is registered across 4 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Tunisia, Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 18 registrations, 12 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.